?>
Logo

VALEANT PHARMACEUTICALS INTERNATIONAL 401k Plan overview

Plan NameVALEANT PHARMACEUTICALS INTERNATIONAL
Plan identification number 550

VALEANT PHARMACEUTICALS INTERNATIONAL Benefits

401k Plan TypeWelfare Benefit
Plan Features/Benefits
  • Temporary disability (accident and sickness)

401k Sponsoring company profile

VALEANT PHARMACEUTICALS INTERNATIONAL, INC. has sponsored the creation of one or more 401k plans.

Company Name:VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Employer identification number (EIN):330628076
NAIC Classification:334610

Additional information about VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

Jurisdiction of Incorporation: State of Delaware Division of Corporations
Incorporation Date:
Company Identification Number: 2422691

More information about VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

Form 5500 Filing Information

Submission information for form 5500 for 401k plan VALEANT PHARMACEUTICALS INTERNATIONAL

Plan id# Filing Submission Date Name of Administrator Date Administrator SignedName of Company SponsorDate Sponsor Signed
5502014-01-01JENNIFER SANSONE2015-10-15
5502012-01-01KELLY WEBBER
5502011-01-01KRISTEN ALLGOR
5502010-01-01KRISTEN ALLGOR
5502009-01-01JEAN ALEXANDER

Plan Statistics for VALEANT PHARMACEUTICALS INTERNATIONAL

401k plan membership statisitcs for VALEANT PHARMACEUTICALS INTERNATIONAL

Measure Date Value
2012: VALEANT PHARMACEUTICALS INTERNATIONAL 2012 401k membership
Total participants, beginning-of-year2012-01-01135
Total number of active participants reported on line 7a of the Form 55002012-01-01295
Number of retired or separated participants receiving benefits2012-01-010
Number of other retired or separated participants entitled to future benefits2012-01-010
Total of all active and inactive participants2012-01-01295
2011: VALEANT PHARMACEUTICALS INTERNATIONAL 2011 401k membership
Total participants, beginning-of-year2011-01-0158
Total number of active participants reported on line 7a of the Form 55002011-01-01135
Number of retired or separated participants receiving benefits2011-01-010
Number of other retired or separated participants entitled to future benefits2011-01-010
Total of all active and inactive participants2011-01-01135
2010: VALEANT PHARMACEUTICALS INTERNATIONAL 2010 401k membership
Total participants, beginning-of-year2010-01-0166
Total number of active participants reported on line 7a of the Form 55002010-01-0158
Number of retired or separated participants receiving benefits2010-01-010
Number of other retired or separated participants entitled to future benefits2010-01-010
Total of all active and inactive participants2010-01-0158
2009: VALEANT PHARMACEUTICALS INTERNATIONAL 2009 401k membership
Total participants, beginning-of-year2009-01-0140
Total number of active participants reported on line 7a of the Form 55002009-01-0166
Number of retired or separated participants receiving benefits2009-01-010
Number of other retired or separated participants entitled to future benefits2009-01-010
Total of all active and inactive participants2009-01-0166
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2009-01-010
Total participants2009-01-0166
Number of participants with account balances2009-01-010
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2009-01-010
Number of employers contributing to the scheme2009-01-010

Financial Data on VALEANT PHARMACEUTICALS INTERNATIONAL

Measure Date Value
2013 : VALEANT PHARMACEUTICALS INTERNATIONAL 2013 401k financial data
Total unrealized appreciation/depreciation of assets2013-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total income from all sources (including contributions)2013-12-31$214,965
Total loss/gain on sale of assets2013-12-31$0
Total of all expenses incurred2013-12-31$320,111
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2013-12-31$299,071
Total contributions o plan (from employers,participants, others, non cash contrinutions)2013-12-31$214,965
Value of total assets at end of year2013-12-31$84,017
Value of total assets at beginning of year2013-12-31$189,163
Total of administrative expenses incurred including professional, contract, advisory and management fees2013-12-31$21,040
Total interest from all sources2013-12-31$0
Total dividends received (eg from common stock, registered investment company shares)2013-12-31$0
Was this plan covered by a fidelity bond2013-12-31Yes
Value of fidelity bond cover2013-12-31$1,000,000
If this is an individual account plan, was there a blackout period2013-12-31No
Were there any nonexempt tranactions with any party-in-interest2013-12-31No
Contributions received from participants2013-12-31$214,965
Administrative expenses (other) incurred2013-12-31$2,500
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Value of net income/loss2013-12-31$-105,146
Value of net assets at end of year (total assets less liabilities)2013-12-31$84,017
Value of net assets at beginning of year (total assets less liabilities)2013-12-31$189,163
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2013-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2013-12-31No
Were any leases to which the plan was party in default or uncollectible2013-12-31No
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2013-12-31$84,017
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2013-12-31$189,163
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2013-12-31$189,163
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2013-12-31No
Was there a failure to transmit to the plan any participant contributions2013-12-31No
Has the plan failed to provide any benefit when due under the plan2013-12-31No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2013-12-31$299,071
Contract administrator fees2013-12-31$18,540
Did the plan have assets held for investment2013-12-31No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2013-12-31No
Accountancy firm name2013-12-31COHN REZNICK
Accountancy firm EIN2013-12-31221478099
2012 : VALEANT PHARMACEUTICALS INTERNATIONAL 2012 401k financial data
Total unrealized appreciation/depreciation of assets2012-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total income from all sources (including contributions)2012-12-31$151,934
Total loss/gain on sale of assets2012-12-31$0
Total of all expenses incurred2012-12-31$130,848
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2012-12-31$115,229
Total contributions o plan (from employers,participants, others, non cash contrinutions)2012-12-31$151,934
Value of total assets at end of year2012-12-31$189,163
Value of total assets at beginning of year2012-12-31$168,077
Total of administrative expenses incurred including professional, contract, advisory and management fees2012-12-31$15,619
Total interest from all sources2012-12-31$0
Total dividends received (eg from common stock, registered investment company shares)2012-12-31$0
Was this plan covered by a fidelity bond2012-12-31Yes
Value of fidelity bond cover2012-12-31$5,000,000
If this is an individual account plan, was there a blackout period2012-12-31No
Were there any nonexempt tranactions with any party-in-interest2012-12-31No
Contributions received from participants2012-12-31$151,934
Administrative expenses (other) incurred2012-12-31$2,583
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Value of net income/loss2012-12-31$21,086
Value of net assets at end of year (total assets less liabilities)2012-12-31$189,163
Value of net assets at beginning of year (total assets less liabilities)2012-12-31$168,077
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2012-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2012-12-31No
Were any leases to which the plan was party in default or uncollectible2012-12-31No
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2012-12-31$189,163
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2012-12-31$168,077
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2012-12-31$168,077
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2012-12-31No
Was there a failure to transmit to the plan any participant contributions2012-12-31No
Has the plan failed to provide any benefit when due under the plan2012-12-31No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2012-12-31$115,229
Contract administrator fees2012-12-31$13,036
Did the plan have assets held for investment2012-12-31No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2012-12-31No
2011 : VALEANT PHARMACEUTICALS INTERNATIONAL 2011 401k financial data
Total income from all sources2011-12-31$46,838
Expenses. Total of all expenses incurred2011-12-31$91,534
Benefits paid (including direct rollovers)2011-12-31$80,398
Total plan assets at end of year2011-12-31$168,077
Total plan assets at beginning of year2011-12-31$212,773
Value of fidelity bond covering the plan2011-12-31$5,000,000
Total contributions received or receivable from participants2011-12-31$46,838
Expenses. Other expenses not covered elsewhere2011-12-31$2,988
Net income (gross income less expenses)2011-12-31$-44,696
Net plan assets at end of year (total assets less liabilities)2011-12-31$168,077
Net plan assets at beginning of year (total assets less liabilities)2011-12-31$212,773
Expenses. Administrative service providers (salaries,fees and commissions)2011-12-31$8,148
2010 : VALEANT PHARMACEUTICALS INTERNATIONAL 2010 401k financial data
Total income from all sources2010-12-31$30,871
Expenses. Total of all expenses incurred2010-12-31$37,461
Benefits paid (including direct rollovers)2010-12-31$30,600
Total plan assets at end of year2010-12-31$212,773
Total plan assets at beginning of year2010-12-31$219,363
Value of fidelity bond covering the plan2010-12-31$5,000,000
Expenses. Other expenses not covered elsewhere2010-12-31$2,322
Net income (gross income less expenses)2010-12-31$-6,590
Net plan assets at end of year (total assets less liabilities)2010-12-31$212,773
Net plan assets at beginning of year (total assets less liabilities)2010-12-31$219,363
Total contributions received or receivable from employer(s)2010-12-31$30,871
Expenses. Administrative service providers (salaries,fees and commissions)2010-12-31$4,539

Form 5500 Responses for VALEANT PHARMACEUTICALS INTERNATIONAL

2012: VALEANT PHARMACEUTICALS INTERNATIONAL 2012 form 5500 responses
2012-01-01Type of plan entitySingle employer plan
2012-01-01Submission has been amendedNo
2012-01-01This submission is the final filingNo
2012-01-01This return/report is a short plan year return/report (less than 12 months)No
2012-01-01Plan is a collectively bargained planNo
2012-01-01Plan funding arrangement – TrustYes
2012-01-01Plan benefit arrangement - TrustYes
2011: VALEANT PHARMACEUTICALS INTERNATIONAL 2011 form 5500 responses
2011-01-01Type of plan entitySingle employer plan
2011-01-01Submission has been amendedNo
2011-01-01This submission is the final filingNo
2011-01-01This return/report is a short plan year return/report (less than 12 months)No
2011-01-01Plan is a collectively bargained planNo
2011-01-01Plan funding arrangement – TrustYes
2011-01-01Plan benefit arrangement - TrustYes
2010: VALEANT PHARMACEUTICALS INTERNATIONAL 2010 form 5500 responses
2010-01-01Type of plan entitySingle employer plan
2010-01-01Submission has been amendedNo
2010-01-01This submission is the final filingNo
2010-01-01This return/report is a short plan year return/report (less than 12 months)No
2010-01-01Plan is a collectively bargained planNo
2010-01-01Plan funding arrangement – TrustYes
2010-01-01Plan benefit arrangement - TrustYes
2009: VALEANT PHARMACEUTICALS INTERNATIONAL 2009 form 5500 responses
2009-01-01Type of plan entitySingle employer plan
2009-01-01Submission has been amendedNo
2009-01-01This submission is the final filingNo
2009-01-01This return/report is a short plan year return/report (less than 12 months)No
2009-01-01Plan is a collectively bargained planNo
2009-01-01Plan funding arrangement – TrustYes
2009-01-01Plan benefit arrangement - TrustYes

Potentially related plans

Was this data useful?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Copyright © Market Footprint Ltd
Contact us   Datalog Company Directory
401k Lookup     VAT Lookup S3